Drug-dependent women leaving prison Mental and Behavioural Disorders
Conditions
Interventions
In the trial, participants will be randomly allocated to be transferred to a women-only, gender and trauma-informed residential rehabilitation service or usual care. Usual care is likely to vary depen
Sponsors
University of York
Eligibility
Sex/Gender
Female
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Women who are 18 years old and over 2. Require support with substance use and associated needs 3. Are willing to receive support or engage in treatment 4. Have capacity under the Mental Health Act 5. Can speak English to a sufficient level to understand the intervention and research materials 6. Are due for release before the end of the recruitment period but with a minimum of 6 weeks left prior to release
Exclusion criteria
Exclusion criteria: 1. On remand 2. Pregnant 3. Has complex unmanaged mental health needs, is not engaging with mental health support or is presenting in crisis 4. Requires personal/nursing care 5. Has a significant cognitive impairment or severe learning difficulties that affect functioning and may require support that cannot be provided onsite
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Abstinence assessed via urine test at 3 and 6 months post randomisation | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient-Reported Outcome Measures (PROMs) using validated questionnaires, including: 1. The Substance Use Recovery Evaluator (SURE), a patient-reported outcome measure of recovery from alcohol and other drugs. 2. Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS), a 7-item questionnaire developed to enable the monitoring of mental wellbeing in the general population and evaluate projects which aim to improve mental wellbeing. 3. PHQ-9, a 9-item, self-completed questionnaire for screening, diagnosing, monitoring and measuring the severity of depression. 4. GAD-7, a 7-item, self-completed questionnaire used as a screening tool and severity measure for generalised anxiety disorder. 5. Modified EQ-5D-5L, an instrument for use as a measure of health outcome that is applicable to a wide range of health conditions and treatments. The descriptive system has five health domains (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) with five response options for each domain (no problems, slight problems, moderate problems, severe problems, and extreme problems). All PROMs collected at baseline, 3 and 6 months post randomisation. 6. Adverse events recorded using a bespoke form designed to record any untoward events during a participant’s time in the trial. These can be reported at any time through a woman’s time on the study but will be specifically asked about 3 and 6 months post randomisation 7. Participant resource use data collected at baseline, 3 and 6 months post randomisation 8. Residential rehabilitation service resource use collected post-intervention 9. Release planning form collected at baseline 10. Treatment as Usual Form collected at 3 and 6 months post randomisation 11. Screening, consent, recruitment and withdrawal data collected throughout the duration of the trial | — |
Countries
England, United Kingdom
Outcome results
None listed